Oral Formulation of Fecal Microbiota Transplant Material (UW-MAD) [19-5957]

The University of Wisconsin-Madison's Purchasing Services Department is seeking bids for an Oral Formulation of Fecal Microbiota Transplant (FMT) Material for clinical trials, specifically for the Department of Medicine - Geriatrics. The procurement involves purchasing approximately 60 doses over a three-year contract period, with each dose consisting of approximately 30 capsules to be ordered on an as-needed basis. Bidders must submit both a hard copy with signatures and an electronic copy (CD, DVD, or Flash Drive) to the University's Purchasing Services office. The initial solicitation was posted on September 17, 2018, with written questions due by September 24, 2018, and bids originally due on October 3, 2018 (later amended to October 12, 2018, at 2:00 PM CDT). Vendors must provide detailed pricing on an Itemized Bid List, including unit list prices, net unit prices, and extended net totals. Bidders are required to demonstrate comprehensive capabilities in donor screening, product formulation, packaging, storage, and regulatory compliance.

The contract opportunity includes specific requirements for vendor qualifications and diversity participation. Bidders must be U.S. vendors with at least two years of demonstrated experience providing FMT materials for clinical treatment or trials, and must be either original manufacturers or authorized distributors. The University has established supplier diversity program goals, including 5% participation for Minority Business Enterprises and 1% for Disabled Veteran-Owned Businesses. Vendors must complete a Vendor Information Form, provide a Client Reference List with three references, and certify non-debarment status. The initial contract term is three years with an option to renew for one additional one-year term by mutual agreement. While specific budget ranges are not explicitly stated, the procurement anticipates purchasing approximately 60 doses over the contract period. The University reserves the right to require oral presentations, product demonstrations, or site visits to validate submitted information, adding an additional layer of vendor evaluation to the procurement process.